Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Strayer

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cold Spring Harbor Protocols|June 3, 2010
Titering replication-defective rSV40 vectorsDavid S Strayer, Christine Mitchell, Dawn A Maier, et al.
Journal of the Neurological Sciences|July 12, 2011
Lymphocyte adhesion to CCR5 ligands is reduced by anti-CCR5 gene deliveryElena Marusich, Jean-Pierre Louboutin, Alena A Chekmasova, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2010
Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damageJean-Pierre Louboutin, Alena Chekmasova, Elena Marusich, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 21, 2003
Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vectorPierre Cordelier, Sandra A Calarota, Roger J Pomerantz, et al.
Journal of Medical Case Reports|December 6, 2008
Prolonged hemophagocytic lymphohistiocytosis syndrome as an initial presentation of Hodgkin lymphoma: a case reportKathryn Chan, Eric Behling, David S Strayer, et al.
Genetic Vaccines and Therapy|August 25, 2004
Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 +/- IL-15Hayley J McKee, Patricia Y T'sao, Maria Vera, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2002
Combination genetic therapy to inhibit HIV-1David S Strayer, Francisco Branco, Julien Landré, et al.
Nature Methods|October 19, 2010
Efficient CNS gene delivery by intravenous injectionJean-Pierre Louboutin, Alena A Chekmasova, Elena Marusich, et al.
Cerebellum (London, England)|August 12, 2010
Gene transfer to the cerebellumJean-Pierre Louboutin, Beverly A S Reyes, Elisabeth J Van Bockstaele, et al.
Alcohol (Fayetteville, N.Y.)|May 8, 2012
Ethanol protects from injury due to ischemia and reperfusion by increasing vascularity via vascular endothelial growth factorJean-Pierre Louboutin, Elena Marusich, Ehre Gao, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cold Spring Harbor Protocols|June 3, 2010
Titering replication-defective rSV40 vectorsDavid S Strayer, Christine Mitchell, Dawn A Maier, et al.
Journal of the Neurological Sciences|July 12, 2011
Lymphocyte adhesion to CCR5 ligands is reduced by anti-CCR5 gene deliveryElena Marusich, Jean-Pierre Louboutin, Alena A Chekmasova, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2010
Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damageJean-Pierre Louboutin, Alena Chekmasova, Elena Marusich, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 21, 2003
Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vectorPierre Cordelier, Sandra A Calarota, Roger J Pomerantz, et al.
Journal of Medical Case Reports|December 6, 2008
Prolonged hemophagocytic lymphohistiocytosis syndrome as an initial presentation of Hodgkin lymphoma: a case reportKathryn Chan, Eric Behling, David S Strayer, et al.
Genetic Vaccines and Therapy|August 25, 2004
Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 +/- IL-15Hayley J McKee, Patricia Y T'sao, Maria Vera, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2002
Combination genetic therapy to inhibit HIV-1David S Strayer, Francisco Branco, Julien Landré, et al.
Nature Methods|October 19, 2010
Efficient CNS gene delivery by intravenous injectionJean-Pierre Louboutin, Alena A Chekmasova, Elena Marusich, et al.
Cerebellum (London, England)|August 12, 2010
Gene transfer to the cerebellumJean-Pierre Louboutin, Beverly A S Reyes, Elisabeth J Van Bockstaele, et al.
Alcohol (Fayetteville, N.Y.)|May 8, 2012
Ethanol protects from injury due to ischemia and reperfusion by increasing vascularity via vascular endothelial growth factorJean-Pierre Louboutin, Elena Marusich, Ehre Gao, et al.
Pageof 5